Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000536419 | SCV000638697 | likely benign | Generalized epilepsy-paroxysmal dyskinesia syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000734743 | SCV000862909 | likely benign | not specified | 2018-08-20 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000734743 | SCV001476646 | benign | not specified | 2020-02-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001796105 | SCV002032527 | uncertain significance | not provided | 2023-05-08 | criteria provided, single submitter | clinical testing | Reported previously as a variant of uncertain significance in a patient with clinically diagnosed Dravet syndrome; however, the patient also harbored variants of uncertain significance in two other genes (Lee et al., 2020); In-frame deletion of 2 amino acids in a repetitive region with no known function; This variant is associated with the following publications: (PMID: 29581464, 33067208) |
Prevention |
RCV004553192 | SCV004116719 | uncertain significance | KCNMA1-related disorder | 2022-11-17 | criteria provided, single submitter | clinical testing | The KCNMA1 c.132_137del6 variant is predicted to result in an in-frame deletion (p.Ser59_Ser60del). This variant was reported as a variant of uncertain significance in an individual with Dravet syndrome; however, this individual had variants in two other genes (Lee et al 2020. PubMed ID: 33067208). This variant is reported in 0.16% of alleles in individuals of Latino descent in gnomAD which is likely too high for a dominant pathogenic variant (http://gnomad.broadinstitute.org/variant/10-79397263-AGAGGAG-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |